U.S. Mortgage REITs Stock News

If you are wondering whether Synaptics shares are offering fair value right now, it helps to look past the headlines and focus on what the numbers are actually saying. The stock last closed at US$85.60, with returns of 15.9% over 30 days and 13.0% year to date, although the 7 day return of a 6.0% decline and a 31.8% decline over three years show a mixed picture for longer term holders. Over the past year, Synaptics shares have returned 2.7%, while the 5 year return stands at a 13.7% decline...

Burke & Herbert Financial Services (BHRB) has capped FY 2025 with fourth quarter revenue of US$86.4 million and EPS of US$2.00, against a trailing twelve month tally of US$340.5 million in revenue and EPS of US$7.72. The company has seen revenue move from US$233.0 million and EPS of about US$2.83 on a trailing basis a year earlier to US$340.5 million and EPS of US$7.72, which helps explain why trailing net income is now US$116.4 million. With net margin reported at 34.2% for the latest twelve...

Madison Square Garden Entertainment Corp. has announced that international superstar Harry Styles will headline 30 consecutive shows at Madison Square Garden from August through October 2026, forming his only US dates that year and the largest single-venue stop on his Together, Together world tour. This residency, combined with MSGE’s record-breaking 2025 Christmas Spectacular attendance, advanced venue technology, and plans for new Sphere locations, highlights how the company is...

Recent commentary on Intellia Therapeutics (NTLA) is focused on safety concerns and regulatory pauses in its transthyretin amyloidosis program, as well as questions about commercial potential for its hereditary angioedema therapy. See our latest analysis for Intellia Therapeutics. Intellia's recent safety headlines come on top of sharp price swings. The company recorded a 1 day share price return of negative 7.99% following a 30 day share price return of 52.55%. Its 1 year total shareholder...

Earlier this week, Array Technologies was swept up in a broad market rally after the US President announced a framework for a future deal with Greenland that eased global trade tensions and lifted sentiment toward renewable energy and infrastructure names. The episode underlines how Array’s investment story can be heavily influenced by shifts in geopolitical risk and market appetite for renewables-linked assets rather than company-specific developments alone. Next, we’ll examine how this...

Medical Properties Trust (MPW) is back in focus as investors react to rising optimism around its upcoming earnings, with upward estimate revisions and heavy call option activity drawing fresh attention to the hospital focused REIT. See our latest analysis for Medical Properties Trust. At a share price of $5.11, Medical Properties Trust has seen mixed recent momentum, with a 1 year total shareholder return of 16.33% set against a 3 year total shareholder return decline of 48.25% and a 5 year...

Inspire Medical Systems recently appointed Matt Osberg as Executive Vice President and Chief Financial Officer, while also issuing updated revenue guidance for the fourth quarter of 2025, full-year 2025, and full-year 2026. These developments coincided with new uncertainty around Medicare reimbursement after two regional contractors removed a key billing code for the company’s hypoglossal nerve stimulation therapy, raising questions about how payment policies could interact with Inspire’s...

In recent days, Cheniere Energy has seen short interest fall markedly while multiple research firms have upgraded their views on the liquefied natural gas exporter, citing supportive demand and project progress. This combination of easing bearish positioning and more favorable analyst commentary signals a meaningful shift in how market participants assess the company’s risk-reward profile. Next, we’ll examine how the sharp reduction in short interest influences Cheniere Energy’s investment...

Earlier this week, Guardant Health received FDA approval for its Guardant360 CDx liquid biopsy as a companion diagnostic to identify BRAF V600E-mutant metastatic colorectal cancer patients eligible for treatment with BRAFTOVI (encorafenib) plus cetuximab and chemotherapy. This marks the test’s first approval in colorectal cancer and its 25th companion diagnostic indication overall, underscoring the expanding role of non-invasive genomic profiling in tailoring treatment when tissue samples...

What Novo Nordisk’s recent performance data tells you Novo Nordisk (NYSE:NVO) has posted mixed return figures, with the share price roughly flat over the past week and slightly higher over the past day, while showing stronger gains over the past month and past 3 months. At the same time, longer term data is uneven, with a negative 1 year total return and a modest negative 3 year total return, set against a very large 5 year total return that points to a materially different outcome for...

United Bancshares (UBOH) has rounded out FY 2025 with fourth quarter total revenue of US$12.6 million and basic EPS of US$1.04, alongside trailing twelve month revenue of US$47.0 million and EPS of US$4.04 that cap a year of stronger profitability. The company has seen total revenue move from US$41.8 million and EPS of US$3.06 on a trailing basis at the end of 2024 to US$47.0 million and US$4.04 respectively, setting up this latest report as a key reference point for how investors judge the...

SLM (SLM) closed out FY 2025 with Q4 revenue of US$472.9 million and basic EPS of US$1.14, while trailing 12 month EPS sat at US$3.52 on revenue of about US$1.7 billion. The company has seen quarterly revenue move from US$281.8 million and EPS of US$0.51 in Q4 FY 2024 to US$472.9 million and EPS of US$1.14 in Q4 FY 2025, alongside trailing 12 month EPS shifting between US$2.73 and US$3.52 over the same window. For investors, the combination of higher trailing margins and these headline...

nLIGHT (NasdaqGS:LASR) has appointed a defense technology veteran to its board of directors. The move is intended to deepen the company’s engagement with aerospace and defense customers. This development is separate from earnings guidance, analyst calls, or broader market moves. For investors watching nLIGHT at a share price of $43.93, the new board member arrives as the company is coming off a period of strong stock performance, including a 270.7% return over the past year and 258.3% over...

Neurocrine Biosciences (NBIX) shares are in focus after new clinical data showed its VMAT2 inhibitor INGREZZA achieved higher target occupancy and greater potency than AUSTEDO XR at therapeutic doses in hyperkinetic movement disorders. See our latest analysis for Neurocrine Biosciences. At a share price of US$136.18, Neurocrine Biosciences has seen a 7.32% 30 day share price decline and a 3.14% year to date share price pullback. Its 3 year total shareholder return of 25.80% contrasts with a 1...

Terrestrial Energy (IMSR) has drawn fresh attention after securing an Other Transaction Authority agreement with the U.S. Department of Energy for Project TEFLA, a pilot facility focused on its proprietary IMSR Fuel Salt production. See our latest analysis for Terrestrial Energy. The OTA news comes after a sharp 76.14% 30 day share price return and an 89.89% year to date share price return to US$12.40, although the 90 day share price return of 38.92% and 1 year total shareholder return of...

SouthState Bank (SSB) has wrapped up FY 2025 with fourth quarter revenue of US$680.3 million and basic EPS of US$2.48, while trailing twelve month revenue came in at about US$2.6 billion and EPS at US$7.90. Over the past year, the bank has seen revenue move from US$1.70 billion on a trailing basis in Q4 2024 to roughly US$2.6 billion by Q4 2025, with trailing EPS rising from US$7.01 to US$7.90 across the same period. This provides a backdrop for investors to weigh that earnings profile...

Old Republic International (ORI) closed out FY 2025 with fourth quarter revenue of US$2.4b, basic EPS of US$0.84 and net income of US$206.3m. The trailing twelve months show revenue of US$9.1b and EPS of US$3.82. Over the past year, revenue has moved from US$8.2b in the trailing period to Q4 2024 to US$9.1b in the latest trailing period, with EPS over those same trailing windows shifting from US$3.30 to US$3.82. For investors, the headline story is that Old Republic paired this top line and...

Business First Bancshares (BFST) has reported a clean set of numbers for FY 2025, with fourth quarter revenue at US$80.0 million and basic EPS of US$0.71. Trailing twelve month revenue reached US$313.4 million and EPS came in at US$2.78, alongside EPS growth of 38.1% over the past year and a five year compound of 12.2% a year. Over recent periods the company has seen quarterly revenue move from US$70.9 million in Q4 2024 to US$79.2 million in Q2 2025 and US$80.0 million in Q4 2025. Quarterly...

In recent months, Alarm.com Holdings reported weak billings growth and signaled only modest revenue expansion, raising questions about customer acquisition momentum and demand trends. Although the company has improved operating margins and profitability, these gains have not fully eased concerns about the resilience of its growth profile. With recent returns under pressure, we’ll explore how Alarm.com’s sluggish billings growth shapes its investment narrative and future prospects. This...

Parke Bancorp (PKBK) has just wrapped up FY 2025 with fourth quarter total revenue of US$22.2 million and basic EPS of US$0.95, capped by trailing twelve month revenue of US$77.4 million and EPS of US$3.20. Over recent periods the company has seen quarterly revenue move from US$16.6 million in Q4 2024 to US$22.2 million in Q4 2025, while basic EPS shifted from US$0.62 to US$0.95. This sets up a story where stronger recent profitability sits against a longer history of earnings pressure. See...

If you are wondering whether CVR Energy at around US$24.54 is offering good value or asking too much, you are exactly who this breakdown is for. The stock has returned 5.3% over the last 7 days, while the 1 year return sits at 18.6%, alongside a 6.9% decline over 30 days and a 2.6% decline year to date. These shifts can change how investors think about both growth potential and risk. Recent coverage of CVR Energy has focused on its role in the energy sector and how investor expectations are...

In mid-January 2026, Intuit opened a new AI-enabled TurboTax flagship store in New York City’s SoHo and completed a nationwide rollout of nearly 600 Expert Office locations and 20 TurboTax Stores, while also securing a new US$2.20 billion revolving credit facility and announcing a technology partnership with BDO Canada. Together, these moves show Intuit pushing deeper into AI-assisted tax and bookkeeping services, blending physical locations, partner ecosystems, and expanded financing...

Why Truist Financial is on investors’ radar today Truist Financial (TFC) is back in focus after recent trading left the share price around $49.57, prompting investors to reassess how its current valuation lines up with its broader return profile. See our latest analysis for Truist Financial. Recent trading has been slightly weaker in the short term, with a 1-day share price return of 1.45% decline and a 30-day share price return of 2.31% decline. However, the 90-day share price return of...

Dollar Tree appointed Daniel Delrosario as Senior Vice President of Investor Relations and Treasurer. Delrosario brings extensive experience in investor relations and treasury roles across major retail and investment organizations. The new role combines responsibility for capital markets engagement and internal financial management. For investors watching Dollar Tree, NasdaqGS:DLTR, this finance leadership change comes with the stock at $128.92. The shares have returned 77.9% over the past...